Minoru Oda

776 total citations
43 papers, 552 citations indexed

About

Minoru Oda is a scholar working on Molecular Biology, Astronomy and Astrophysics and Pharmacology. According to data from OpenAlex, Minoru Oda has authored 43 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Astronomy and Astrophysics and 7 papers in Pharmacology. Recurrent topics in Minoru Oda's work include Astrophysical Phenomena and Observations (5 papers), Enzyme function and inhibition (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Minoru Oda is often cited by papers focused on Astrophysical Phenomena and Observations (5 papers), Enzyme function and inhibition (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Minoru Oda collaborates with scholars based in Japan, United States and France. Minoru Oda's co-authors include Yoshitaka Ino, Takuo Sato, Takuo Aoyama, Masayuki Ozeki, Koichi Yokota, Akira Yamashita, Tatsuya Funahashi, Tomomichi Sone, Noriko Yamamoto and Masahiro Iwaki and has published in prestigious journals such as Nature, Physics Today and Kidney International.

In The Last Decade

Minoru Oda

39 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Oda Japan 8 110 80 64 61 61 43 552
Ajit Suri United States 20 127 1.2× 204 2.5× 52 0.8× 82 1.3× 59 1.0× 54 955
Hiroaki Satoh Japan 17 148 1.3× 79 1.0× 34 0.5× 87 1.4× 117 1.9× 90 1.2k
M. Błażek Czechia 13 58 0.5× 51 0.6× 64 1.0× 9 0.1× 50 0.8× 68 486
Mary W. Smith United States 20 448 4.1× 30 0.4× 69 1.1× 30 0.5× 68 1.1× 35 1.2k
SangYun Lee South Korea 17 372 3.4× 97 1.2× 27 0.4× 28 0.5× 49 0.8× 44 1.1k
Pradip Datta United States 18 180 1.6× 14 0.2× 24 0.4× 57 0.9× 137 2.2× 75 869
B. Thomsen Denmark 22 113 1.0× 518 6.5× 213 3.3× 30 0.5× 57 0.9× 66 1.7k
Kazuyoshi Kumagai Japan 19 207 1.9× 164 2.0× 69 1.1× 48 0.8× 20 0.3× 54 990
M. Williams United States 12 354 3.2× 14 0.2× 209 3.3× 27 0.4× 32 0.5× 33 1.2k
P. Camus France 17 155 1.4× 26 0.3× 83 1.3× 40 0.7× 54 0.9× 47 939

Countries citing papers authored by Minoru Oda

Since Specialization
Citations

This map shows the geographic impact of Minoru Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Oda more than expected).

Fields of papers citing papers by Minoru Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Oda. The network helps show where Minoru Oda may publish in the future.

Co-authorship network of co-authors of Minoru Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Oda. A scholar is included among the top collaborators of Minoru Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Oda. Minoru Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodashima, Shinya, Yuki Shimizu, Minoru Oda, et al.. (2023). Risk Factors for Elevated D-Dimer Levels in Patients with Gastrointestinal Tumors Treated with Endoscopic Submucosal Dissection. Journal of Clinical Medicine. 12(16). 5229–5229. 3 indexed citations
2.
Yamaori, Satoshi, Tatsuya Funahashi, Toshiyuki Kimura, et al.. (2006). Involvement of Human Blood Arylesterases and Liver Microsomal Carboxylesterases in Nafamostat Hydrolysis. Drug Metabolism and Pharmacokinetics. 21(2). 147–155. 57 indexed citations
3.
Abe, Takaya, Minoru Oda, Hirohito Hasegawa, et al.. (2003). Effect of β2-microglobulin adsorption column on dialysis-related amyloidosis. Kidney International. 64(4). 1522–1528. 36 indexed citations
4.
Kotoku, J., Kazuo Makishima, Y. Okada, et al.. (2003). Fourier synthesis image reconstruction by use of one-dimensional position-sensitive detectors. Applied Optics. 42(20). 4176–4176. 5 indexed citations
5.
Ueda, Nobuhisa, et al.. (1999). Hemostatic effect of a novel sheeted fibrin adhesive agent, TO-193, on experimental incision models.. Folia Pharmacologica Japonica. 113(3). 177–184. 3 indexed citations
6.
Yamazaki, Hideya, et al.. (1999). Adhesive and sealing effects of TO-193 on tissues and organs in various experimental models.. Folia Pharmacologica Japonica. 113(4). 269–276. 1 indexed citations
7.
Yokota, Koichi, et al.. (1997). The mechanism of action of KBT-3022, a new antiplatelet agent. General Pharmacology The Vascular System. 28(2). 229–235. 5 indexed citations
8.
Yamamoto, Noriko, Koichi Yokota, Akira Yamashita, & Minoru Oda. (1996). Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo. European Journal of Pharmacology. 297(3). 225–231. 4 indexed citations
9.
Yokota, Koichi, Akira Yamashita, & Minoru Oda. (1995). Anti-thrombotic Activity of KBT-3022 in Experimental Models of Thrombosis. The Japanese Journal of Pharmacology. 68(2). 201–206. 11 indexed citations
10.
Yamamoto, Noriko, Koichi Yokota, Mikio Yoshidomi, Akira Yamashita, & Minoru Oda. (1995). Protective Effect of KBT-3022, a New Cyclooxygenase Inhibitor, in Cerebral Hypoxia and Ischemia. The Japanese Journal of Pharmacology. 69(4). 421–428. 7 indexed citations
12.
Tanaka, Junichi, et al.. (1992). Increased monoamine turnover in the subfornical organ area following body fluid depletion. Neuroreport. 3(10). 901–904. 12 indexed citations
13.
Ino, Yoshitaka, et al.. (1989). Inhibitory effect of N-.ALPHA.-((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro.. Folia Pharmacologica Japonica. 93(4). 219–224. 2 indexed citations
14.
Oda, Minoru, et al.. (1989). Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs.. Folia Pharmacologica Japonica. 93(4). 235–243. 1 indexed citations
15.
Oda, Minoru, et al.. (1986). Inhibitory effect of nafamostat mesilate (FUT-175) on O2- production in rat polymorphonuclear leucocytes.. Folia Pharmacologica Japonica. 87(5). 521–526. 3 indexed citations
16.
Sato, Takuo, et al.. (1986). Inhibitory Effects of a Novel Synthetic Protease Inhibitor, FUT-175, on the Paw Edema in Rats and Zymosan-induced Complement Activation in Vitro. The Japanese Journal of Pharmacology. 42(4). 587–589. 2 indexed citations
17.
Iwaki, Masahiro, et al.. (1984). . Folia Pharmacologica Japonica. 84(4). 373–384. 1 indexed citations
18.
Murakami, Toshio, Hajime Inoue, Katsuji Koyama, et al.. (1980). Two Successive X-Ray Bursts at Ten-Minute Interval from 1608—522. Publications of the Astronomical Society of Japan. 32(3). 543–546. 4 indexed citations
19.
Iida, Shoji, et al.. (1978). The Ultra-Sonic Flow Meter for the Sodium Cooled Fast Breeder Reactor. Transactions of the Society of Instrument and Control Engineers. 14(2). 178–183.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026